Subcutaneous Methylnaltrexone Provides Long-Term Laxation in Patients with Chronic Non-Malignant Pain and Opioid-Induced Constipation

被引：0
|
作者：
Webster, L. R. [1 ]
Michna, E. [2 ]
Khan, A. [3 ]
Maller, E. [4 ]
Tzanis, E. [4 ]
Israel, R. [5 ]
机构：
[1] Lifetree Clin Res & Pain Clin, Salt Lake City, UT USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] NW Clin Res, Bellevue, WA USA
[4] Wyeth Res, Collegeville, PA USA
[5] Progen Pharmaceut Inc, Tarrytown, NY USA
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2011年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
153
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] Characteristics of Gastrointestinal Adverse Events in Patients With Opioid-Induced Constipation and Chronic Non-Malignant Pain Treated With Subcutaneous Methylnaltrexone
    Randazzo, Bruce P.
    Duerden, Marc E.
    Schulman, Seth
    Tzanis, Evan L.
    Yu, Dahong
    Randazzo, Bruce P.
    Manley, Amy
    GASTROENTEROLOGY, 2010, 138 (05) : S167 - S167
  • [2] EFFICACY OF SUBCUTANEOUS METHYLNALTREXONE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN SUBGROUPS OF PATIENTS WITH CHRONIC, NONMALIGNANT PAIN
    Duerden, Marc
    Schulman, Seth
    Tzanis, Evan
    Zhang, Haiyang
    Manley, Amy
    Randazzo, Bruce
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 267 - 268
  • [3] Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial
    Webster, Lynn R.
    Michna, Edward
    Khan, Arif
    Israel, Robert J.
    Harper, Joseph R.
    PAIN MEDICINE, 2017, 18 (08) : 1496 - 1504
  • [4] Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Patients With Chronic, Nonmalignant Pain: A Randomized Controlled Study
    Michna, Edward
    Blonsky, E. Richard
    Schulman, Seth
    Tzanis, Evan
    Manley, Amy
    Zhang, Haiying
    Iyer, Shrividya
    Randazzo, Bruce
    JOURNAL OF PAIN, 2011, 12 (05): : 554 - 562
  • [5] Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
    Rauck, Richard L.
    Slatkin, Neal E.
    Stambler, Nancy
    Israel, Robert J.
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 139 - 150
  • [6] Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients
    Kyle, Gaye
    INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2009, 15 (11) : 533 - 540
  • [7] CUMULATIVE LAXATION RESPONSE WITH METHYLNALTREXONE: IMPLICATIONS FOR HOSPITALIZED PATIENTS WITH ADVANCED ILLNESS AND OPIOID-INDUCED CONSTIPATION
    Farchadi, David
    Slatkin, Neal E.
    Stambler, Nancy
    Israel, Robert J.
    Matus, Michael
    GASTROENTEROLOGY, 2020, 158 (06) : S399 - S400
  • [8] Methylnaltrexone induces laxation in patients with advanced illness suffering from opioid-induced constipation.
    Karver, S.
    Thomas, J.
    Cooney, G.
    Chamberlain, B.
    Watt, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S76 - S76
  • [9] EFFECT OF SUBCUTANEOUS (SC) METHYLNALTREXONE ON GENERIC HEALTH RELATED QUALITY OF LIFE USING THE EQ-5D INDEX SCORES IN PATIENTS WITH CHRONIC NON-MALIGNANT PAIN AND OPIOID-INDUCED CONSTIPATION
    Iyer, S.
    Randazzo, B.
    Tzanis, E.
    Schulman, S.
    Zhang, H.
    Wang, W.
    Manley, A.
    VALUE IN HEALTH, 2009, 12 (07) : A348 - A349
  • [10] Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain
    Spierings, Egilius L. H.
    Rauck, Richard
    Brewer, Randall
    Marcuard, Stefano
    Vallejo, Ricardo
    PAIN PRACTICE, 2016, 16 (08) : 985 - 993
12345